Evidence map›Paper›PMID 27708726›Full record

ArticleThe open dentistry journal2016

Bisphenol A Release: Survey of the Composition of Dental Composite Resins.

Elisabeth Dursun, Hélène Fron-Chabouis, Jean-Pierre Attal, Anne Raskin

Abstract read
In one paragraph

Article in The open dentistry journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A Systematic Review of Exposure to Bisphenol A from Dental Treatment.JDR clinical and translational research · 2019
    Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Bibliometric Analysis of the Toxicity of Bisphenol A.International journal of environmental research and public health · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elisabeth DursunUnité de Recherche en Biomatériaux, Innovations et Interfaces - EA 4462, Faculté de Chirurgie Dentaire, Université Paris Descartes, Paris, Groupe Hospitalier Mondor-Chenevier, Créteil, France.
Hélène Fron-ChabouisUnité de Recherche en Biomatériaux, Innovations et Interfaces - EA 4462, Faculté de Chirurgie Dentaire, Université Paris Descartes, Paris, Hôpital Charles Foix, Ivry-sur-Seine, France.
Jean-Pierre AttalUnité de Recherche en Biomatériaux, Innovations et Interfaces - EA 4462, Faculté de Chirurgie Dentaire, Université Paris Descartes, Paris, Hôpital Charles Foix, Ivry-sur-Seine, France.
Anne RaskinUMR 7268 ADES, EFS, CNRS Faculté d'Odontologie, Université d'Aix-Marseille, Marseille, Pôle d'Odontologie, UF des soins spécifiques, APHM, Hôpital de la Timone, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBisphenol A (BPA) is an endocrine disruptor with potential toxicity. Composite resins may not contain pure BPA, but its derivatives are widely used. Several studies found doses of BPA or its derivatives in saliva or urine of patients after composite resin placement.

objectiveThe aims of this study were to establish an exhaustive list of composite resins marketed in Europe and their composition, and to assess the extent of BPA derivatives used.

methodsA research on manufacturers' websites was performed to reference all composite resins marketed in Europe, then their composition was determined from both material safety data sheets and a standardized questionnaire sent to manufacturers. Manufacturers had to indicate whether their product contained the monomers listed, add other monomers if necessary, or indicate "not disclosed".

results160 composite resins were identified from 31 manufacturers and 23 manufacturers (74.2%) responded to the survey. From the survey and websites, the composition of 130 composite resins (81.2%) was: 112 (86.2%) based on BPA derivatives, 97 (74.7%) on bis-GMA, 17 (13.1%) without monomer derived from BPA (UDMA, sometimes with TEGDMA) and 6 (4.6%) with UDMA (only); 1 (0.8%) did not contain a BPA derivative or UDMA or TEGDMA. Pure BPA was never reported.

conclusionThis work has established a list of 18 composite resins that contain no BPA derivative. Manufacturers should be required to report the exact composition of their products as it often remains unclear or incomplete.

Indexed as

BiocompatibilityBisphenol AComposite resinMonomer

Identifiers

PMID27708726
PMCPMC5039892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.